Celularity (CELU) Earnings Analysis

Celularity (CELU) next reports earnings on 2026-08-12. Last quarter (2026-04-30) it beat with EPS -0.95 USD vs -1.5 USD est (+36.7%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E -0.21.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CELU next report earnings?

Next earnings date2026-08-12
Consensus EPS estimaten/a
Revenue estimaten/a

CELU earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-30-0.95 USD-1.5 USD+36.7%Beat
2025-11-14-0.88 USD-1.5 USD+41.3%Beat
2025-08-29-0.83949 USDn/an/an/a
2025-05-08-0.59 USD-1.5 USD+60.7%Beat
2024-12-06-0.73 USD-1.4 USD+47.9%Beat
2024-11-07-0.3 USD-1.4 USD+78.6%Beat
2024-07-310.536 USDn/an/an/a

Beat rate: 5/5 (100%) over reported quarters with consensus data.

CELU valuation and analyst view

Trailing P/E-0.21
Trailing EPS-3.58274 USD
Price / book-0.52
Dividend yield0.00%
Market cap0.02B
Analyst consensusBuy (3 buy / 2 hold / 1 sell)

Related research pages

Frequently asked questions

When is Celularity (CELU)'s next earnings date?

Celularity is next scheduled to report on 2026-08-12.

Did CELU beat earnings last quarter?

In its 2026-04-30 report, CELU posted EPS of -0.95 USD versus a -1.5 USD estimate — a beat of 36.7%.

What is CELU's earnings track record?

Over the last 5 reported quarters with consensus data, CELU beat estimates 5 times (100%).

What is CELU's current P/E ratio and EPS?

CELU trades at a trailing P/E of -0.21 on trailing EPS of -3.582736952736374 USD.

What do analysts rate CELU?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 3 buy, 2 hold, 1 sell, 0 strong sell).